Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Income (2016 - 2025)

Organogenesis Holdings has reported Net Income over the past 10 years, most recently at $53.2 million for Q4 2025.

  • Quarterly results put Net Income at $53.2 million for Q4 2025, up 593.34% from a year ago — trailing twelve months through Dec 2025 was $46.5 million (up 5304.41% YoY), and the annual figure for FY2025 was $46.5 million, up 5304.41%.
  • Net Income for Q4 2025 was $53.2 million at Organogenesis Holdings, up from $21.6 million in the prior quarter.
  • Over the last five years, Net Income for ORGO hit a ceiling of $53.2 million in Q4 2025 and a floor of -$18.8 million in Q1 2025.
  • Median Net Income over the past 5 years was $6.5 million (2023), compared with a mean of $8.2 million.
  • Biggest five-year swings in Net Income: skyrocketed 1450.88% in 2024 and later crashed 797.29% in 2025.
  • Organogenesis Holdings' Net Income stood at $51.0 million in 2021, then crashed by 81.44% to $9.5 million in 2022, then plummeted by 106.0% to -$568000.0 in 2023, then skyrocketed by 1450.88% to $7.7 million in 2024, then soared by 593.34% to $53.2 million in 2025.
  • The last three reported values for Net Income were $53.2 million (Q4 2025), $21.6 million (Q3 2025), and -$9.4 million (Q2 2025) per Business Quant data.